Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...

Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 ...

Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant ...

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...

January 10, 2025, marks the second anniversary of the death of Tyre Nichols, a 29-year-old Black man who was restrained and ...

Sac Bee columnist LeBron Hill only associated Tyre Nichols’ killing as a tragedy. But in Sacramento he sees his full legacy.

The parking attendant didn’t attend to what I had said. Baffled, he soon assumed an aggressive demeanour; maybe as a defence ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

In a Patreon post by industry insider Daniel Richtman (via ComicBook ), he shared a little insight into the now scrapped ...

Swiss-French archaeologists have uncovered the 4,100-year-old tomb in Egypt that belonged to a royal physician with a very ...

According to industry insider Daniel Richtman, Marvel's team is still rewriting the script for the movie after Kevin Fiege ...

STX-478 is under clinical development by Scorpion Therapeutics and currently in Phase II for Endometrial Cancer.